[LRMR] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -132.94%
YoY- 42.74%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,330 -6,674 -6,076 -8,628 -3,704 -5 -14,570 -15.44%
Tax -32 -35 -1,175 -4,286 -8,482 330 0 -
NP -11,330 -6,674 -6,076 -8,628 -3,704 -5 -14,570 -15.44%
Tax Rate - - - - - - - -
Total Cost 11,330 6,674 6,076 8,628 3,704 5 14,570 -15.44%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.21 -0.72 -0.66 -0.94 -0.40 -0.00 -4.52 -58.49%
EPS Diluted -1.21 -0.72 -0.66 -0.94 -0.40 -0.00 -4.52 -58.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.